WalletMed develops a subdermal biosensor that continuously collects metabolic data from bodily fluids, powered by a smartwatch with an NFC module. This technology enables users to monitor health metrics in real-time, facilitating early detection of metabolic diseases and reducing preventable healthcare costs.
Funding
$107.9K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Lifestyle-related noncommunicable diseases account for a significant number of deaths annually, and a substantial amount is spent on preventable care due to late detection and monitoring of metabolic issues. Current methods lack continuous, real-time data collection for effective early detection and personalized management of metabolic health.
Solution
WalletMed offers a continuous metabolic monitoring system featuring a subdermal biosensor powered by a smartwatch with NFC. The implant collects raw metabolic data, which is then analyzed using bioinformatics and AI to cross-check metabolic markers for diseases. The system provides personalized lifestyle and health recommendations based on individual results, along with access to consultations with experts such as doctors and dieticians. WalletMed aims to create a looped, end-to-end healthcare ecosystem, including a marketplace for condition-related drugs and private health clinics for treatment and monitoring.
Target Audience
The primary target audience includes individuals at risk of or affected by metabolic diseases, healthcare providers seeking advanced monitoring tools, and health-conscious consumers interested in proactive health management.
Features
- Everlasting subdermal implant for continuous collection of raw metabolic data.
- Smartwatch with an NFC module to ensure the implant is always powered.
- AI-driven bioinformatics for cross-checking metabolic markers and disease detection.
- Personalized lifestyle and health recommendations based on individual metabolic results.
- Access to consultations with healthcare experts (doctors, dieticians, etc.).
- Marketplace for condition-related drugs, both prescription and over-the-counter.
- Network of private health clinics for patient treatment and implant-based monitoring.